Director, Global Market Access and Pricing, Immunology
Sanofi
About this role
The Director, Global Market Access and Pricing, Immunology at Sanofi leads the global market access perspective for immunology pipeline assets, focusing on maximizing pricing and access potential across indications. The role is a core member of Global Project Teams, collaborating cross-functionally with R&D, commercial, HEVA, regulatory, and country teams to align development and early commercialization strategy. Based in Cambridge, MA, the position supports early market access planning and capability improvements across the franchise.
Skills
Qualifications
About Sanofi
sanofi.comSanofi is a research & development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines & vaccines.
Recent company news
Sanofi (NASDAQ:SNY) Hits New 52-Week Low - Should You Sell?
21 hours ago
Alchemab Therapeutics lures Sanofi exec to be its CBO
2 days ago
Sanofi: An Undervalued Stock For Long-Term Dividend Growth Investors (SNY)
2 days ago
NANOBODY® Technology Platform
Aug 26, 2025
Is Sanofi (ENXTPA:SAN) Now An Opportunity After A 25.8% One Year Share Price Slide?
3 days ago
About Sanofi
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Sanofi.
Salary
$173k – $249k
per year
More jobs at Sanofi
Similar Jobs
Director, Global Market Access, Immunology
MSD
Senior Director, Pricing Strategy - Immunology
Regeneron Pharmaceuticals
Director, US Market Access Pipeline, Immunology
AbbVie
Associate Director, Global Market Access & Pricing
Genmab
Director, Global Market Access & Pricing
Genmab
Senior Director, Global Market Access and Pricing, Solid Tumor
Genmab